ABOUT US
Mission and Objectives
Message from the Chairman
Message from the Secretary General
Board of Directors
Our Members
Inspection Board
Who Are We?
Committees
Intellectual Property Rights Committee
GCP Committee
GPP Committee
PR Committee
Regulatory Affairs Committee
Charter
Name of the Association
Head Office
Mission and Activities of the Association
Membership
Terms of Joining and Terminating
Bodies of the Association
General Assembly
Board of Directors
Inspection Board
Internal Audit
Secretary General
Acquisition of Property
Revenues and Expenditures of the Assoc.
Dissolution of the Association
Records of the Association
Charter Amendments
Absence of Ruling
Applicable Language
Founders of the Association
Code of Promotion
Internet User Guide
SECTORIAL DATA
Announcements of Moh & Legislation
Frequently Asked Questions
Data & Analysis Center
NEW DRUGS AND R&D
What does it mean to be researcher?
What is an “Original” drug?
Implementations (Original & Generic)
Patent Protection
Data Exclusivity
PRESS ROOM
Press Announcement
Press Releases
News
Insider AİFD
Activities
Reflections in the Press
AIFD REPORTS AND SURVEYS
AIFD ACADEMY
About AİFD Academy
AİFD Academy Final Declaration
AİFD Academy E-Bulletin Membership
TR
EN
Home Page
»
PRESS ROOM
» News
News
Melih Memecan Reelected as AİFD chairman
27.05.2011
İlaç Sektöründe Bıçak Kemiğe Dayandı, Bazı Yatırımlar İptal
12.05.2011
Pushed To The Limit, Pharmaceutical Sector Calls Off Some Investments
11.05.2011
293 New Drugs Await Regulatory Approval
19.04.2011
Data On Turkey Is Available From AiFD Center For Data And Analysis
08.02.2011
Press Announcement
Press Releases
News
Insider AİFD
Activities
Reflections in the Press
MEMBER LOGIN
İşletim sisteminiz Flash Ögeleri Desteklemiyor. Yüklemek için
tıklayınız.
INSIDER AIFD
Our pharmaceutical industry, global competition and opportunities
SEARCH IN SITE
DID YOU KNOW THAT…?
IMPORTANT TERMS
SITE MAP
USEFUL LINKS
CONFIDENTIALITY-TERMS OF USE
CONTACT
Abbott
•
Actelion
•
AIFD
•
Alcon
•
Alexion İlaç Ticaret Ltd. Şti.
•
Allergan İlaçları Ticaret A.Ş.
•
Amgen
•
Astellas
•
AstraZeneca
•
Bausch+Lomb Sağlık Optik Ürünleri Tic. A.Ş.
•
Bayer Türk Kimya San. Ltd. Şti.
•
Boehringer Ingelheim
•
Bristol-Myers Squibb
•
Celgene
•
Chiesi
•
Daiichi-Sankyo
•
Eczacıbaşı-Baxter
•
Ferring
•
Fresenius Kabi
•
Gilead Sciences İlaç.Tic. Ltd. Şti.
•
GlaxoSmithKline
•
IBSA İlaç San. ve Tic. Ltd. Şti.
•
Intendis
•
ISection
•
İ.E.Ulagay
•
Johnson&Johnson
•
Lilly
•
Lundbeck İlaç Tic.Ltd. Şti.
•
Merck Serono
•
MSD Türkiye
•
Nestle
•
Novartis Sağlık Ürünleri
•
Novo Nordisk
•
Nutricia Klinik Beslenme
•
OTHERS
•
Pfizer İlaçları Ltd. Şti
•
Roche Müstahzarları San. A.Ş.
•
Sanofi-aventis
•
Servier
•
Takeda İlaçları Tic Ltd Şti
•
U.C.B. Pharma
•
AİFD is a member of IFPMA – International Federation of Pharmaceutical Manufacturers and Associations and EFPIA (European Federation of Pharmaceutical Industries and Associations).
© Association of Research-Based Pharmaceutical Companies
Last Update :
02.02.2012